Breaking: Unprecedented Growth Forecasted in the Biosimilar Contract Manufacturing Market
The biosimilar contract manufacturing market is on the cusp of a significant transformation, with projections indicating a remarkable growth trajectory. By 2035, the market is expected to reach USD 51.9 billion, showcasing an impressive compound annual growth rate (CAGR) of 18.9%. This growth is fueled by the escalating demand for affordable biologics and advancements in manufacturing...
0 Comments 0 Shares 70 Views 0 Reviews